View Older Stories View More Recent Stories

Mar 26, 2026 10:56AM William Blair stays Outperform on Viking Therapeutic (VKTX) amid 'torrid pace' in advancing VK2735
Mar 26, 2026 10:54AM William Blair on Dianthus Therapeutics (DNTH): FDA removing ANA criteria 'an incremental positive'
Mar 26, 2026 10:35AM Secondary Market Hits Record $220 Billion in 2025
Mar 26, 2026 09:21AM William Blair Reiterates Outperform Rating on MillerKnoll (MLKN) amid post-earnings selloff
Mar 26, 2026 08:48AM William Blair stays Outperform on Cardiff Oncology (CRDF) despite adoption hurdles, dilution risks
Mar 26, 2026 08:08AM William Blair stays Outperform rated on Karman Holdings Inc (KRMN) after solid earnings, guidance raise
Mar 26, 2026 07:43AM Adobe downgraded at William Blair on intensifying competitive pressure
Mar 26, 2026 04:37AM William Blair Downgrades Adobe (ADBE) to Market Perform
Mar 25, 2026 05:45PM William Blair stays Outperform on Ionis Pharmaceuticals (IONS); pricing update 'positive'
Mar 25, 2026 05:40PM William Blair stays Market Perform on WillScot Holdings Corp (WSC) amid soft Feb. dodge starts
Mar 25, 2026 12:57PM William Blair stays Outperform on Beam Therapeutics Inc (BEAM) after "decisive validation' of BEAM-302 profile
Mar 25, 2026 11:55AM Generac stock tumbles as data center deal hopes disappoint
Mar 25, 2026 08:50AM William Blair on Arm Holdings (ARM): new CPU product to pressure margins, but increases earnings power
Mar 25, 2026 06:02AM William Blair Reiterates Outperform Rating on Circle Internet Group (CRCL)
Mar 24, 2026 03:52PM William Blair stays Outperform on Vertical Aerospace Ltd. (EVTL) despite $110 million funding gap
Mar 24, 2026 11:40AM William Blair on Watsco (WSO): selloff 'an overreaction' to HD's Mingledorff's acquisition
Mar 24, 2026 10:50AM William Blair on Neurogene (NGNE): dosing update further de-risks NGN-401 profile
Mar 23, 2026 04:44PM William Blair maintains Outperform rated on Cabaletta Bio Inc. (CABA) amid trial progress
Mar 23, 2026 01:10PM Defense firm AEVEX files for NYSE IPO
Mar 23, 2026 11:51AM William Blair on Pyxis Oncology Inc. (PYXS): 'encouraged' by enrollment pace of dose-expansion study
Mar 23, 2026 09:51AM William Blair on Tarsus Pharmaceuticals (TARS): 'benefits from the large and motivated patient population'
Mar 23, 2026 09:50AM William Blair on MaxCyte Inc. (MXCT): CFO appointment 'not all that needle-moving'
Mar 23, 2026 08:48AM William Blair on Insmed (INSM): 'data overall supports approval'
Mar 23, 2026 07:08AM William Blair Downgrades Avepoint Inc. (AVPT) to Market Perform
Mar 23, 2026 07:06AM William Blair Downgrades Dropbox (DBX) to Underperform
Mar 23, 2026 07:05AM William Blair Double Downgrades GitLab Inc (GTLB) to Underperform
Mar 23, 2026 06:28AM William Blair on GoDaddy Inc (GDDY): 'we are optimistic'
Mar 23, 2026 06:01AM William Blair Starts Eupraxia Pharmaceuticals (EPRX) at Outperform
Mar 20, 2026 12:34PM William Blair on Aveanna Healthcare Holdings Inc (AVAH): 'Pullback Presents Attractive Risk/Reward'
Mar 20, 2026 10:32AM William Blair on Compass Diversified (CODI): not without risks, but undervalued
Mar 19, 2026 04:13PM William Blair Reiterates Outperform Rating on Chewy Inc. (CHWY) ahead of earnings
Mar 19, 2026 02:38PM William Blair on Larimar Therapeutics (LRMR): not without risk but favorable risk/reward
Mar 19, 2026 09:00AM Wolfspeed raises $475.9 million through convertible notes and stock sale
Mar 19, 2026 08:59AM Wolfspeed Announces Subscriptions for $379 Million of Convertible Notes and $96.9 Million of Common Stock and Pre-Funded Warrants
Mar 19, 2026 08:37AM William Blair on Aveanna Healthcare (AVAH) after earnings: valuation presents compelling risk/reward
Mar 19, 2026 05:12AM William Blair Upgrades Five Below (FIVE) to Outperform
Mar 18, 2026 03:28PM William Blair stays Outperform on CoStar Group (CSGP): Homes.com premarket expansion 'net positive'
Mar 18, 2026 11:53AM William Blair Reiterates Market Perform Rating on Carlisle (CSL) amid roofing price hikes
Mar 18, 2026 10:21AM William Blair stays Outperform on AAON Inc (AAON): 'pullback a buying opprotunity'
Mar 18, 2026 09:01AM William Blair on Oklo (OKLO): risks to pre-rev biz, but Oklo a leader making progress under reg environment
Mar 18, 2026 08:30AM William Blair on NVIDIA (NVDA): positioned to capture 'lion's share' of AI infra spend 'for years to come'
Mar 17, 2026 05:13PM William Blair on Lantheus Holdings (LNTH) following PDUFA date extended: 'optimistic' co will receive approval
Mar 17, 2026 01:30PM William Blair on Kalaris (KLRS) after positive data: 'blockbuster potential for TH103'
Mar 17, 2026 08:07AM Mastercard deepens stablecoin push with up to $1.8 billion BVNK acquisition
Mar 17, 2026 07:00AM Audax Private Equity Acquires Property Management Company AKAM
Mar 17, 2026 07:00AM Nautic Partners Announces Sale of Property Management Company AKAM
Mar 16, 2026 11:51AM William Blair Reiterates Outperform Rating on Structure Therapeutics (GPCR): 'considerable market opportunity for aleniglipron'
Mar 16, 2026 10:14AM William Blair Reiterates Market Perform Rating on Neogenomics (NEO) following 'much-needed positive catalyst'
Mar 16, 2026 10:09AM William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): 'should see multiple value inflection for shares'
Mar 16, 2026 07:03AM Alto Neuroscience raises $120 million in private placement financing
View More Recent Stories View Older Stories